[Utility of SPECT with 99m Tc-tetrofosmin and stimulus with dipyridamole in patients with permanent ventricular pacemakers]
- PMID: 11333817
- DOI: 10.1016/s0212-6982(01)71933-7
[Utility of SPECT with 99m Tc-tetrofosmin and stimulus with dipyridamole in patients with permanent ventricular pacemakers]
Abstract
Background and objective: Patients with permanent ventricular pacemakers (PP) are a difficult subgroup to assess in the study of coronary artery disease. The objective of this study was to evaluate the diagnostic value of the myocardial perfusion scintigraphy with 99mTC-Tetrofosmin (Tc-Tf) and stimulus with dipyridamole in patients with PP and suspected coronary artery disease.
Patients and methods: Fourteen patients with suspected coronary artery disease and without structural cardiopathy, who underwent Tc-Tf and cardiac catheterization, were studied retrospectively. Sensitivity, specificity, predictive values and Kappa index were calculated for the diagnosis of coronary artery disease, multivessel disease, and for each one of the coronary arteries (left anterior descending, right coronary, and circumflex). In addition, the correlation between the number of territories with perfusion defects and the number of diseased vessels was studied.
Results: In regards to the diagnosis of coronary artery disease, sensitivity, specificity, positive predictive value, negative predictive value and the Kappa index were 100%, 50%, 83%, 100% and 0.55, respectively. For multi-vessel disease, these values were 83%, 64%, 64%, 83% and 0.43 respectively. The correlation coefficient between the number of territories with perfusion defects and the number of diseased vessels was 0.61 (p = 0.02). In the diagnosis of anterior descending disease, sensitivity and specificity were 83% and 88% respectively. For the right coronary artery, these values were 100% and 44% and for the circumflex artery 38% and 83%, respectively.
Conclusion: In patients with PP and suspected coronary artery disease, myocardial perfusion scintigraphy with Tc-Tf and stimulus with dipyridamole is of great value in the diagnosis of coronary artery disease and in the assessment of its extension.
Similar articles
-
[Meaning of clinical and electrical positivity in the myocardial perfusion scintigraphy during the administration of dipyridamole].Rev Esp Med Nucl. 2001 Feb;20(1):4-10. Rev Esp Med Nucl. 2001. PMID: 11181323 Spanish.
-
[Usefulness of spect with 99mTc-tetrofosmin and stimulus with dipyridamole in patients with left bundle branch block of His].Rev Esp Med Nucl. 2000 Feb;19(1):3-10. Rev Esp Med Nucl. 2000. PMID: 10758431 Review. Spanish.
-
Comparison of technetium-99m tetrofosmin and thallium-201 single-photon emission computed tomographic imaging for detection of myocardial perfusion defects in patients with coronary artery disease.J Am Coll Cardiol. 1998 Feb;31(2):331-7. doi: 10.1016/s0735-1097(97)00484-1. J Am Coll Cardiol. 1998. PMID: 9462576
-
Diagnostic accuracy of dipyridamole technetium 99m-labeled sestamibi myocardial tomography for detection of coronary artery disease.J Nucl Cardiol. 1997 Jan-Feb;4(1 Pt 1):18-24. doi: 10.1016/s1071-3581(97)90045-3. J Nucl Cardiol. 1997. PMID: 9138835
-
Enhanced detection of reversible perfusion defects by Tc-99m sestamibi compared to Tc-99m tetrofosmin during vasodilator stress SPECT imaging in mild-to-moderate coronary artery disease.J Am Coll Cardiol. 2001 Feb;37(2):458-62. doi: 10.1016/s0735-1097(00)01148-7. J Am Coll Cardiol. 2001. PMID: 11216963
Cited by
-
The prognostic value of pharmacologic stress myocardial perfusion imaging in patients with permanent pacemakers.J Nucl Cardiol. 2005 Jan-Feb;12(1):37-42. doi: 10.1016/j.nuclcard.2004.08.004. J Nucl Cardiol. 2005. PMID: 15682364 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous